Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 58 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Plain-language summary

Abstract INTRODUCTION: Research on the potential role of cardiometabolic diseases (CMDs) as risk factors for Lewy body dementia (LBD) is limited, and findings from existing studies remain inconclusive. We investigated the geospatial patterns of CMDs and the association with LBD across the United States (U.S.). METHODS We performed an observational case-control study using a nationwide, population-based Medicare dataset of 75,847 incident LBD and 379,235 controls from 2017 and 2018 and computed the odd ratios (ORs) and 95% confidence intervals (CIs) between eight CMDs and LBD, adjusted for age, sex, race, smoking, healthcare utilization, and area deprivation index. At the county-level, we computed and mapped the standardized incidence ratios (SIRs) of LBD. We then computed the standardized prevalence ratios (SPRs) for the CMDs that were positively associated with LBD to investigate the geospatial patterns of the association between these CMDs and LBD across the U.S. RESULTS Compared to controls, our LBD cases were older and male. Hispanic, non-Hispanic Black, and Asian/Pacific Islander beneficiaries had higher odds of LBD compared to the non-Hispanic White beneficiaries. Of the eight CMDs examined, stroke (OR = 1.99, 95% CI = 1.95–2.02) was positively associated with LBD risk, while the other CMDs were inversely associated with LBD risk. There was a substantial geographic variation of prevalent stroke and incident LBD across the U.S., with the highest spatial correlation in the South and Central Appalachia. DISCUSSION Stroke is associated with a higher LBD risk. We observed higher SIRs for LBD and SPRs for stroke among beneficiaries living in the Southern U.S.

What this study adds

Evidence grade: Moderate

This is a case-control study. In a Medicare case-control study of 75,847 incident Lewy body dementia cases and 379,235 controls, stroke was positively associated with Lewy body dementia risk while the other seven cardiometabolic diseases examined were inversely associated. Reported effect size: OR = 1.99.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Karway, G. K., Krzyzanowski, B., Killion, J. A., Faust, I. M., Laurido-Soto, O., & Racette, B. A. (2026). Geospatial analysis of the association of cardiometabolic diseases and incident Lewy body dementia in the Medicare population. npj Parkinson s Disease. https://doi.org/10.1038/s41531-026-01557-8

Vancouver

Karway GK, Krzyzanowski B, Killion JA, Faust IM, Laurido-Soto O, Racette BA. Geospatial analysis of the association of cardiometabolic diseases and incident Lewy body dementia in the Medicare population. npj Parkinson s Disease. 2026. doi:10.1038/s41531-026-01557-8.

BibTeX

@article{karway2026-b956e865,
  author  = {Karway, George K. and Krzyzanowski, Brittany and Killion, Jordan A. and Faust, Irene M. and Laurido-Soto, Osvaldo and Racette, Brad Alan},
  title   = {{Geospatial analysis of the association of cardiometabolic diseases and incident Lewy body dementia in the Medicare population}},
  journal = {npj Parkinson s Disease},
  year    = {2026},
  doi     = {10.1038/s41531-026-01557-8},
  url     = {https://doi.org/10.1038/s41531-026-01557-8}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In a Medicare case-control study of 75,847 incident Lewy body dementia cases and 379,235 controls, stroke was positively associated with Lewy body dementia risk while the other seven cardiometabolic diseases examined were inversely associated. Geographic variation in these associations was observed across the United States.

Study details

How this study scored 58/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 6 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 1 of 2; Free to read 2 of 2. 37 of the 64 points it could be judged on, which is 58 of 100. Total 58 of 100.37 of the 64 points we could judge = 58 of 100

Published in a peer-reviewed journal, and it is a case-control study. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 37 of the 64 points we could judge it on, which is 58 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (npj Parkinson s Disease)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 6 / 12 A case-control study
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 37 / 64 Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 37 of the 64 points we could judge it on is 58 out of 100.
Total 58 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →